You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pretreated

Showing 1 - 25 of 772
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Migraine Without Aura Trial in Copenhagen (Levcromakalim, Placebo)

Recruiting
  • Migraine Without Aura
  • Copenhagen, Denmark
    Danish Headache Center
May 25, 2023

Migraine Without Aura Trial in Copenhagen (Sildenafil, Placebo)

Recruiting
  • Migraine Without Aura
  • Copenhagen, Denmark
    Danish Headache Center
May 25, 2023

Cholangiocarcinoma Trial in Düsseldorf (Ivosidenib Oral Tablet)

Recruiting
  • Cholangiocarcinoma
  • Ivosidenib Oral Tablet
  • Düsseldorf, Germany
    Klinik für Gastroenterologie, Hepatologie und Infektiologie Univ
May 17, 2023

Hepatitis B, Chronic Trial in Seoul (Vemliver tablet, Entecavir Tablet)

Recruiting
  • Hepatitis B, Chronic
  • Vemliver tablet
  • Entecavir Tablet
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 17, 2023

Metastatic Castration-Resistant Prostate Cancer Patients Trial in Copenhagen (Irofulven, Prednisolone 10 mg)

Active, not recruiting
  • Metastatic Castration-Resistant Prostate Cancer Patients
  • Copenhagen, Denmark
    Rigshospitalet, Dept. Of Oncology
Feb 1, 2023

Melanoma Stage III, Melanoma Stage IV Trial in Jette (Regorafenib 40 MG Oral Tablet)

Not yet recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Regorafenib 40 MG Oral Tablet
  • Jette, Brussel, Belgium
    UZ Brussels
May 6, 2022

NSCLC Trial in United States (ALT-803, Nivolumab)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • ALT-803
  • Nivolumab
  • Weston, Florida
  • +3 more
Dec 5, 2022

Metastatic Triple Negative Breast Cancer Trial in New Haven (Tumor infiltrating lymphocytes (TIL) LN-145)

Recruiting
  • Metastatic Triple Negative Breast Cancer
  • Tumor infiltrating lymphocytes (TIL) LN-145
  • New Haven, Connecticut
    Yale School of Medicine
Jul 20, 2022

HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Shanghai (Trastuzumab plus chemo, Trastuzumab in combination with

Recruiting
  • HER2-positive Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab plus chemotherapy
  • Trastuzumab in combination with pyrotinib plus chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 20, 2022

Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • Breast Cancer
  • Neratinib Oral Tablet
  • Ruxolitinib Oral Tablet
  • Dallas, Texas
    Baylor University Medical Center, Baylor Charles A Sammons Cance
Aug 22, 2023

Pancreatic Cancer Trial in Herlev (Nivolumab, Ipilimumab, Tocilizumab)

Terminated
  • Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Mar 15, 2022

Breast Cancer Trial (Tucatinib, Eribulin, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jul 12, 2022

Non-small-cell Lung Cancer Patients Trial in Roma (Durvalumab, Olaparib tablet, Single-agent chemo)

Recruiting
  • Non-small-cell Lung Cancer Patients
  • Roma, RM, Italy
    Istituti Fisioterapici Ospitalieri- Ifo - Istituto Regina Elena
Sep 30, 2022

Adenocarcinoma of the Lung Trial in Großhansdorf (nintedanib-nivolumab combination therapy)

Active, not recruiting
  • Adenocarcinoma of the Lung
  • nintedanib-nivolumab combination therapy
  • Großhansdorf, Germany
    LungenClinic Grosshansdorf
Dec 14, 2021

NSCLC Trial in Worldwide (Afatinib)

Completed
Has Results
  • NSCLC
  • Köln, Germany
  • +4 more
Aug 23, 2022

Breast Cancer Trial in Shanghai (sintilimab, bevacizumab biosimilar, pegylated liposomal doxorubicin)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 22, 2022

Metastatic Colon Cancer Trial in Italy (Trifluridine Tipiracil, Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX])

Completed
  • Metastatic Colon Cancer
  • Trifluridine Tipiracil
  • Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]
  • Monserrato, CA, Italy
  • +7 more
Jul 21, 2022

NSCLC, NSCLC Metastatic, NSCLC Recurrent Trial in Worldwide (Alectinib)

Terminated
  • Non-small Cell Lung Cancer
  • +2 more
  • Brussels, Belgium
  • +18 more
Aug 23, 2022

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Bendamustine, Alemtuzumab)

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Innsbruck, Tirol, Austria
  • +6 more
Feb 15, 2022

Patients With Chronic Low Back Pain Due to Degenerative Lumbar Disc Trial in Seongnam-si (administered an autologous

Enrolling by invitation
  • Patients With Chronic Low Back Pain Due to Degenerative Lumbar Disc
  • administered an autologous adipose-derived mesenchymal stem cell spheroid pretreated with matrillin 3
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    CHA University, CHA Bundang Medical Center
Aug 19, 2021

Patients With Relapsed/Refractory Multiple Myeloma

Not yet recruiting
  • Relapsed and Refractory Multiple Myeloma (RRMM)
  • Non-Interventional
  • (no location specified)
Dec 21, 2022

Brolucizumab in Pre-treated nAMD in the Real-world Setting

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Brolucizumab
  • (no location specified)
Aug 8, 2022

NSCLC Trial in Guangzhou (Savolitinib, Docetaxel)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Department of Thoracic Surgery and Oncology, The First Affiliate
Mar 17, 2023

Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)

Recruiting
  • Stage IV Melanoma
  • Stage III Melanoma
  • Jette, Brussels, Belgium
    Universitair Ziekenhuis Brussel
Sep 29, 2021

Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)

Active, not recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022